Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

The Role of Fungi in the Etiology of Multiple Sclerosis.

Benito-León J, Laurence M.

Front Neurol. 2017 Oct 16;8:535. doi: 10.3389/fneur.2017.00535. eCollection 2017.

2.

Erectile dysfunction and the risk of prostate cancer.

Lin WY, Chang YH, Lin CL, Kao CH, Wu HC.

Oncotarget. 2017 Apr 13;8(32):52690-52698. doi: 10.18632/oncotarget.17082. eCollection 2017 Aug 8.

3.

Going viral? Linking the etiology of human prostate cancer to the PCA3 long noncoding RNA and oncogenic viruses.

Teixeira AA, Marchiò S, Dias-Neto E, Nunes DN, da Silva IT, Chackerian B, Barry M, Lauer RC, Giordano RJ, Sidman RL, Wheeler CM, Cavenee WK, Pasqualini R, Arap W.

EMBO Mol Med. 2017 Oct;9(10):1327-1330. doi: 10.15252/emmm.201708072. No abstract available.

4.

Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction.

Kanda Y, Osaki M, Okada F.

Int J Mol Sci. 2017 Apr 19;18(4). pii: E867. doi: 10.3390/ijms18040867. Review.

5.

The association between sexual function and prostate cancer risk in US veterans.

Zapata DF, Howard LE, Frank J, Simon RM, Hoyo C, Grant DJ, Freedland SJ, Vidal AC.

Asian J Androl. 2017 Mar-Apr;19(2):191-195. doi: 10.4103/1008-682X.184869.

6.

Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort.

Bonilla C, Lewis SJ, Martin RM, Donovan JL, Hamdy FC, Neal DE, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Lathrop M, Davey Smith G; PRACTICAL consortium.

BMC Med. 2016 Apr 4;14:66. doi: 10.1186/s12916-016-0602-x.

7.

Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up.

Rider JR, Wilson KM, Sinnott JA, Kelly RS, Mucci LA, Giovannucci EL.

Eur Urol. 2016 Dec;70(6):974-982. doi: 10.1016/j.eururo.2016.03.027. Epub 2016 Mar 28.

8.

Reduced risk of prostate cancer in childless men as compared to fathers: a systematic review and meta-analysis.

Mao Y, Xu X, Zheng X, Xie L.

Sci Rep. 2016 Jan 11;6:19210. doi: 10.1038/srep19210. Review.

10.

Gonorrhea and Prostate Cancer Incidence: An Updated Meta-Analysis of 21 Epidemiologic Studies.

Lian WQ, Luo F, Song XL, Lu YJ, Zhao SC.

Med Sci Monit. 2015 Jul 1;21:1902-10. doi: 10.12659/MSM.893579.

11.

Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis.

Weng PH, Huang YL, Page JH, Chen JH, Xu J, Koutros S, Berndt S, Chanock S, Yeager M, Witte JS, Eeles RA, Easton DF, Neal DE, Donovan J, Hamdy FC, Muir KR, Giles G, Severi G, Smith JR, Balistreri CR, Shui IM, Chen YC.

PLoS One. 2014 Oct 31;9(10):e110569. doi: 10.1371/journal.pone.0110569. eCollection 2014. Review.

12.

Fathering of dizygotic twins and risk of prostate cancer: nationwide, population-based case-control study.

Wirén S, Drevin L, Akre O, Robinson D, Stattin P.

PLoS One. 2014 Oct 22;9(10):e110506. doi: 10.1371/journal.pone.0110506. eCollection 2014.

13.

Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells.

Mukherjee S, Siddiqui MA, Dayal S, Ayoub YZ, Malathi K.

J Inflamm Res. 2014 Jun 17;7:89-101. doi: 10.2147/JIR.S61365. eCollection 2014.

14.

The same and not the same: heterogeneous functional activation of prostate tumor cells by TLR ligation.

Rezania S, Amirmozaffari N, Rashidi N, Mirzadegan E, Zarei S, Ghasemi J, Zarei O, Katouzian L, Zarnani AH.

Cancer Cell Int. 2014 Jun 19;14:54. doi: 10.1186/1475-2867-14-54. eCollection 2014.

15.

Prostate cancer in young men: an important clinical entity.

Salinas CA, Tsodikov A, Ishak-Howard M, Cooney KA.

Nat Rev Urol. 2014 Jun;11(6):317-23. doi: 10.1038/nrurol.2014.91. Epub 2014 May 13. Review.

16.

Circumcision and prostate cancer: a population-based case-control study in Montréal, Canada.

Spence AR, Rousseau MC, Karakiewicz PI, Parent MÉ.

BJU Int. 2014 Dec;114(6b):E90-E98. doi: 10.1111/bju.12741. Epub 2014 May 28.

17.

Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France.

Menegaux F, Anger A, Randrianasolo H, Mulot C, Laurent-Puig P, Iborra F, Bringer JP, Leizour B, Thuret R, Lamy PJ, Rébillard X, Trétarre B; EPICAP Study Group.

BMC Cancer. 2014 Feb 19;14:106. doi: 10.1186/1471-2407-14-106.

18.

MSMB variation and prostate cancer risk: clues towards a possible fungal etiology.

Sutcliffe S, De Marzo AM, Sfanos KS, Laurence M.

Prostate. 2014 May;74(6):569-78. doi: 10.1002/pros.22778. Epub 2014 Jan 24. Review.

19.

The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer.

Elkahwaji JE.

Res Rep Urol. 2012 Dec 31;5:1-10. doi: 10.2147/RRU.S23386. Review.

20.

Is prostatic adenocarcinoma in a relationship with Human Papilloma Virus in Isfahan -Iran.

Mokhtari M, Taghizadeh F, Hani M.

J Res Med Sci. 2013 Aug;18(8):707-10.

Supplemental Content

Support Center